Analysis of Real-World Data Details Skin Toxicities Across Eleven Targeted Cancer Drugs
A pharmacovigilance study examining 34,088 adverse event reports identified distinct skin toxicity profiles and early onset patterns across eleven vascular ...
A pharmacovigilance study examining 34,088 adverse event reports identified distinct skin toxicity profiles and early onset patterns across eleven vascular ...
Researchers have identified an immune-enriched molecular subtype of hepatocellular carcinoma defined by tertiary lymphoid structures and coordinated plasma cell and ...
The Alliance for Clinical Trials in Oncology is highlighting eight ongoing clinical studies investigating new detection, treatment, and survivorship strategies ...
A comprehensive oncology review highlights how microRNA-371a-3p and circulating tumor DNA offer superior diagnostic and prognostic accuracy while novel agents ...
A cell-based study showed that a tightly regulated expression platform reproduced variant-specific responses to cabozantinib in engineered human A549 lung ...
Preclinical hepatocellular carcinoma models showed that blocking ACSS2 or autophagy enhanced cabozantinib’s antitumor activity by disrupting a TFEB-linked protective response.
A Japanese case report links the kidney cancer drug cabozantinib to microthrombi that produced skin necrosis mimicking necrotizing fasciitis.
A post hoc analysis of the CheckMate 9ER trial links early worsening of bone pain and sleep quality to higher ...
A two-stage estimation analysis of the CheckMate 9ER trial shows that removing the influence of subsequent therapy substantially enlarges the ...
Cabozantinib, an innovative oral tyrosine kinase inhibitor, has recently received approval from the U.S. Food and Drug Administration (FDA) for ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.